A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation
Corresponding Author
Stephen O'Neill
MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK
Correspondence
Stephen O'Neill MB, BCh, BAO, MSc, MRCSEd, AFHEA, MAcadMEd, MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Chancellor's Building, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, UK.
Tel.: 0044-7849592113;
fax: 0044-1312429451;
e-mail: [email protected]
Search for more papers by this authorAmanda Roebuck
MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK
Search for more papers by this authorEmily Khoo
MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK
Search for more papers by this authorStephen J. Wigmore
MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK
Search for more papers by this authorEwen M. Harrison
MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK
Search for more papers by this authorCorresponding Author
Stephen O'Neill
MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK
Correspondence
Stephen O'Neill MB, BCh, BAO, MSc, MRCSEd, AFHEA, MAcadMEd, MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Chancellor's Building, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, UK.
Tel.: 0044-7849592113;
fax: 0044-1312429451;
e-mail: [email protected]
Search for more papers by this authorAmanda Roebuck
MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK
Search for more papers by this authorEmily Khoo
MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK
Search for more papers by this authorStephen J. Wigmore
MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK
Search for more papers by this authorEwen M. Harrison
MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK
Search for more papers by this authorSummary
Donation after cardiac death (DCD) liver transplantation is increasingly common but concerns exist over the development of biliary complications and ischemic cholangiopathy (IC). This study aimed to compare outcomes between DCD and donation after brain death (DBD) liver grafts. Studies reporting on post-transplantation outcomes after Maastricht category III DCD liver transplantation were screened for inclusion. Odds ratios (OR) with 95% confidence intervals were produced using random-effects models for the incidence of biliary complications, IC, graft and recipient survival. Meta-regression was undertaken to identify between-study predictors of effect size for biliary complications and IC. PROSPERO Record: CRD42012002113. Twenty-five studies with 62 184 liver transplant recipients (DCD = 2478 and DBD = 59 706) were included. In comparison with DBD, there was a significant increase in biliary complications [OR = 2.4 (1.9, 3.1); P < 0.00001] and IC [OR = 10.5 (5.7, 19.5); P < 0.00001] following DCD liver transplantation. In comparison with DBD, at 1 year [OR = 0.7 (0.5, 0.8); P = 0.0002] and 3 years [OR = 0.6 (0.5, 0.8); P = 0.001], there was a significant decrease in graft survival following DCD liver transplantation. At 1 year, there was also a nonsignificant decrease [OR = 0.8 (0.6, 1.0); P = 0.08] and by 3 years a significant decrease [OR = 0.7 (0.5, 1.0); P = 0.04] found in recipient survival following DCD liver transplantation. Eleven factors were entered into meta-regression models, but none explained the variability in effect size between studies. DCD liver transplantation is associated with an increase in biliary complications, IC, graft loss and mortality. Significant unexplained differences in effect size exist between centers.
References
- 1Abou AA, Abouljoud M, Yoshida A, et al. Biliary complications after orthotopic liver transplantation from donors after cardiac death: broad spectrum of disease. Transplant Proc 2010; 42: 3392.
- 2Devey L, Wigmore SJ. Non-heart-beating organ donation. Br J Surg 2009; 96: 833.
- 3Taner CB, Bulatao IG, Keaveny AP, et al. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transpl 2011; 17: 641.
- 4 NHSBT. Transplant Activity in the UK. UK Transplant Registry Activity Report 2012–13.
- 5 NHSBT. Transplant Activity in the UK. UK Transplant Registry Activity Report 2003–04. http://www.organdonation.nhs.uk/statistics/transplant_activity_report/
- 6Selck FW, Grossman EB, Ratner LE, Renz JF. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg 2008; 248: 599.
- 7Mateo R, Cho Y, Singh G, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant 2006; 6: 791.
- 8Jay C, Ladner D, Wang E, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant – an analysis of the national registry. J Hepatol 2011; 55: 808.
- 9Doshi MD, Hunsicker LG. Short- and long-term outcomes with the use of kidneys and livers donated after cardiac death. Am J Transplant 2007; 7: 122.
- 10Dubbeld J, Hoekstra H, Farid W, et al. Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg 2010; 97: 744.
- 11DeOliveira ML, Jassem W, Valente R, et al. Biliary complications after liver transplantation using grafts from donors after cardiac death: results from a matched control study in a single large volume center. Ann Surg 2011; 254: 716; discussion 22–3.
- 12Seehofer D, Eurich D, Veltzke-Schlieker W, Neuhaus P. Biliary complications after liver transplantation: old problems and new challenges. Am J Transplant 2013; 13: 253.
- 13op den Dries S, Buis CI, Adelmeijer J, et al. The combination of primary sclerosing cholangitis and CCR5-Delta32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation. Liver Int 2011; 31: 1102.
- 14Wigmore SJ. Current challenges in liver transplantation following donation after cardiac death. Transplantation 2010; 90: 1048.
- 15Skaro AI, Wang E, Lyuksemburg V, Abecassis M. Donation after cardiac death liver transplantation: time for policy to catch up with practice. Liver Transpl 2012; 18: 5.
- 16Noack K, Bronk SF, Kato A, Gores GJ. The greater vulnerability of bile duct cells to reoxygenation injury than to anoxia. Implications for the pathogenesis of biliary strictures after liver transplantation. Transplantation 1993; 56: 495.
- 17Karimian N, Op den Dries S, Porte RJ. The origin of biliary strictures after liver transplantation: is it the amount of epithelial injury or insufficient regeneration that counts? J Hepatol 2013; 58: 1065.
- 18Buis CI, Geuken E, Visser DS, et al. Altered bile composition after liver transplantation is associated with the development of nonanastomotic biliary strictures. J Hepatol 2009; 50: 69.
- 19Skaro AI, Jay CL, Baker TB, et al. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery 2009; 146: 543.
- 20Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg 2011; 253: 817.
- 21Jay CL, Lyuksemburg V, Kang R, et al. The increased costs of donation after cardiac death liver transplantation: caveat emptor. Ann Surg 2010; 251: 743.
- 22Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.
- 23Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc 1995; 27: 2893.
- 24Fondevila C, Hessheimer AJ, Flores E, et al. Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation. Am J Transplant 2012; 12: 162.
- 25Jimenez-Galanes S, Meneu-Diaz MJ, Elola-Olaso AM, et al. Liver transplantation using uncontrolled non-heart-beating donors under normothermic extracorporeal membrane oxygenation. Liver Transpl 2009; 15: 1110.
- 26Suarez F, Otero A, Solla M, et al. Biliary complications after liver transplantation from maastricht category-2 non-heart-beating donors. Transplantation 2008; 85: 9.
- 27Otero A, Gomez-Gutierrez M, Suarez F, et al. Liver transplantation from maastricht category 2 non-heart-beating donors: a source to increase the donor pool? Transplant Proc 2004; 36: 747.
- 28Pine JK, Aldouri A, Young AL, et al. Liver transplantation following donation after cardiac death: an analysis using matched pairs. Liver Transpl 2009; 15: 1072.
- 29Abt P, Crawford M, Desai N, Markmann J, Olthoff K, Shaked A. Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation 2003; 75: 1659.
- 30Chan EY, Olson LC, Kisthard JA, et al. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl 2008; 14: 604.
- 31de Vera ME, Lopez-Solis R, Dvorchik I, et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant 2009; 9: 773.
- 32Dezza MC, Berrevoet F, Sainz-Barriga M, et al. The choice of recipient does not have a bearing on early outcome in liver transplant patients receiving grafts from non-heart-beating donors: a reappraisal? Transplant Proc 2007; 39: 2675.
- 33Foley DP, Fernandez LA, Leverson G, et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg 2005; 242: 724.
- 34Fujita S, Mizuno S, Fujikawa T, et al. Liver transplantation from donation after cardiac death: a single center experience. Transplantation 2007; 84: 46.
- 35Grewal HP, Willingham DL, Nguyen J, et al. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl 2009; 15: 1028.
- 36Kaczmarek B, Manas MD, Jaques BC, Talbot D. Ischemic cholangiopathy after liver transplantation from controlled non-heart-beating donors-a single-center experience. Transplant Proc 2007; 39: 2793.
- 37Manzarbeitia CY, Ortiz JA, Jeon H, et al. Long-term outcome of controlled, non-heart-beating donor liver transplantation. Transplantation 2004; 78: 211.
- 38Nguyen JH, Bonatti H, Dickson RC, et al. Long-term outcomes of donation after cardiac death liver allografts from a single center. Clin Transplant 2009; 23: 168.
- 39Tao R, Ruppert K, Cruz RJ Jr, et al. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts. Liver Transpl 2010; 16: 1288.
- 40Yamamoto S, Wilczek HE, Duraj FF, Groth CG, Ericzon BG. Liver transplantation with grafts from controlled donors after cardiac death: a 20-year follow-up at a single center. Am J Transplant 2010; 10: 602.
- 41Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Wiley, 2011: 672 pp.
- 42Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011; 343: d4002.
- 43Rucker G, Schwarzer G, Carpenter J. Arcsine test for publication bias in meta-analyses with binary outcomes. Stat Med 2008; 27: 746.
- 44Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006; 25: 3443.
- 45Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw 2010; 36: 1.
- 46Detry O, Donckier V, Lucidi V, et al. Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003–2007. Transpl Int 2010; 23: 611.
- 47Detry O, Seydel B, Delbouille MH, et al. Liver transplant donation after cardiac death: experience at the University of Liege. Transplant Proc 2009; 41: 582.
- 48Mathur AK, Heimbach J, Steffick DE, Sonnenday CJ, Goodrich NP, Merion RM. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant 2010; 10: 2512.
- 49Monbaliu D, Van Gelder F, Troisi R, et al. Liver transplantation using non-heart-beating donors: Belgian experience. Transplant Proc 2007; 39: 1481.
- 50Taner CB, Bulatao IG, Willingham DL, et al. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl 2012; 18: 100.
- 51Tariciotti L, Rocha C, Perera MT, et al. Is it time to extend liver acceptance criteria for controlled donors after cardiac death? Transplantation 2011; 92: 1140.
- 52Detry O, Deroover A, Meurisse N, et al. Donor age as a risk factor in donation after circulatory death liver transplantation in a controlled withdrawal protocol programme. Br J Surg 2014; 101: 784-92.
- 53Harring TR, Nguyen NT, Cotton RT, et al. Liver transplantation with donation after cardiac death donors: a comprehensive update. J Surg Res 2012; 178: 502.
- 54Croome KP, Wall W, Quan D, et al. Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts. Hepatobiliary Pancreat Dis Int 2012; 11: 372.
- 55Angelico M, Nardi A, Romagnoli R, et al. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study. Dig Liver Dis 2014; 46: 340.
- 56Croome KP, Wall W, Chandok N, Beck G, Marotta P, Hernandez-Alejandro R. Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts. Liver Transpl 2013; 19: 1214.
- 57Ortiz J, Feyssa EL, Parsikia A, et al. Severe hepatitis C virus recurrence is nearly universal after donation after cardiac death liver transplant. Exp Clin Transplant 2011; 9: 105.
- 58Meurisse N, Vanden Bussche S, Jochmans I, et al. Outcomes of liver transplantations using donations after circulatory death: a single-center experience. Transplant Proc 2012; 44: 2868.
- 59Croome KP, McAlister V, Adams P, Marotta P, Wall W, Hernandez-Alejandro R. Endoscopic management of biliary complications following liver transplantation after donation from cardiac death donors. Can J Gastroenterol 2012; 26: 607.
- 60D'Alessandro AM, Hoffmann RM, Knechtle SJ, et al. Liver transplantation from controlled non-heart-beating donors. Surgery 2000; 128: 579.
- 61Callaghan CJ, Charman SC, Muiesan P, Powell JJ, Gimson AE, van der Meulen JH. Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study. BMJ Open 2013; 3: e003287.
- 62Axelrod DA, Lentine KL, Xiao H, et al. National assessment of early biliary complications following liver transplantation: incidence and outcomes. Liver Transpl 2014; 20: 446.
- 63Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg 2011; 253: 259.
- 64Lang TA, Altman DG. Basic Statistical Reporting for Articles Published in Biomedical Journals: The “Statistical Analyses and Methods in the Published Literature” or The SAMPL Guidelines. Science Editors’ Handbook, European Association of Science Editors 2013.
- 65Buis CI, Verdonk RC, Van der Jagt EJ, et al. Nonanastomotic biliary strictures after liver transplantation, part 1: Radiological features and risk factors for early vs. late presentation. Liver Transpl 2007; 13: 708.
- 66Brunner SM, Junger H, Ruemmele P, et al. Bile duct damage after cold storage of deceased donor livers predicts biliary complications after liver transplantation. J Hepatol 2013; 58: 1133.